Pharmacist and PhD researcher Hannah Cleary tells us about her work on long-acting injectables (LAIs) to improve drug ...

Deciding what to eat, where to get it, and how those choices align with health goals or cultural habits are ordinary parts of ...

Ultragenyx sold some of its drug royalties for a treatment for rare bone disease to Omers Life Sciences for $400 million. The biopharmaceutical company said Tuesday the sale includes an additional 25% ...

A Columbus biotech has landed another $18 million toward seeking FDA approval for an eye drop to treat diabetic dry eye, ...

The official opening will be headlined by Dr Nomalungelo Gina, Deputy Minister of Science, Technology and Innovation, who ...

Frontier Scientific Solutions is creating the nation’s first “scheduled service” flights for the pharmaceutical and ...

A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns ...

Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Rising tensions between the NHS and pharmaceutical companies are testing how much the health service can afford to pay for new branded medicines.

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies ...